On this episode of Stock Movers:
- Bayer said an experimental stroke-prevention drug showed positive results in a late-stage study, a boost for the German company as it seeks to counter sales declines from aging blockbuster medicines.
- Hensoldt and other European defense shares are on watch over the latest news around Ukraine
- BHP Group has walked away from a fresh takeover approach for Anglo American Plc, ending an unexpected and short-lived attempt by the world’s largest miner to thwart a planned tie-up between its smaller rival and Canada’s Teck Resources Ltd.

Nvidia Rises, Broadcom Drops, Campbell's Slumps on Sales Drop
04:49

Snowflake Jumps, Hewlett Packard Slides, and Ultragenyx Sinks as Rare Disorder Drug Fails Late Stage Trial
03:29

Nvidia and Meta; Snowflake's Surge
03:02